IAS 1, OCI, items that may be and will not be reclassified, reclassifications and tax, equity accounted entities

GlaxoSmithKline plc – Annual report – 31 December 2017

Industry: pharmaceuticals

[Note: the company has not yet adopted IFRS 9 and therefore gains and losses on afs investments may be reclassified to income]